With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Read more below: https://lnkd.in/gKRw4d43 #biotechnews #biotech #pharmafunding
Mantell Associates
Executive Search Services
City of London, England 163,939 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
Get directions
150 Minories
City of London, England EC3N 1LS, GB
-
Get directions
2 S Biscayne Blvd
Miami, Florida 33131, US
Employees at Mantell Associates
Updates
-
Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs as demand for complex therapies grows. The contract development and manufacturing organization, which became independent in 2023, is investing heavily in facilities in the U.S. and Germany. Read more below: https://lnkd.in/eibkMtH7 #pharmanews #biopharmanews #cdmo
-
Roche’s Gazyva is at it again. After an FDA nod in lupus nephritis marked a fresh chapter for the aging blood cancer blockbuster just two weeks ago, the drug is looking to solidify its position as a contender in the lupus treatment landscape with a positive trial result that could support an expansion into the most common type of lupus. Read more below: https://lnkd.in/eq25YFQY #pharmanews #pharma #autoimmune
-
Our Halloween Sales Day on Friday saw a great effort from everyone - from high activity across the floor, to incredible teamwork, to everyone's Halloween costumes! Shout out to our winning team George Watts, Fernand Desjarlais and Kasey Merxhani! Some individual successes: - George Watts for topping the leaderboard - Robin Mantell and Chiara Pasti coming in as a close 2nd and 3rd place - Kasey Merxhani for winning best dressed! We are hiring experienced Life Science recruiters who are looking for their next step - get in touch with Maddy Savva to find out what you can achieve at MA! #halloween #recruitmentlondon #lifesciencerecruitment
-
-
Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its goodie bag, the company announced on Oct. 29. Read more below: https://lnkd.in/eD_D-Uu3 #biotechnews #clinicaltrials #biotech
-
Chinese life science contracting giant WuXi AppTec is taking another step to zero in on its core offerings by hiving off two China-based subsidiaries. Read more below: https://lnkd.in/eDV7TPjD #biotechnews #clinicalresearch #biotech
-
Mantell Associates is partnered with an established and growing CDMO specialised in solid dosage pharmaceutical manufacturing, who is seeking a decisive and experienced Head of Supply Chain to lead its supply chain operations in Brandenburg. Apply for this role online - https://lnkd.in/e7YxBSDX - or contact Conor O'Shea on +44 (0)20 3854 7700. #supplychainjobs #cdmojobs #supplychain
-
-
The MA Halloween Sales Day is underway! We've got a full day of competitions, energy, and prizes (as well as forfeits...) all driving serious performance across the Sales floor. "Pumpkin Sprint" and Ghosted Revival" complete ✅ Breakfast ordered in ✅ "Trick or Treat Hour" underway ✅ Already seen some big wins, and the competitive spirit between teams is exactly what you'd expect from a floor of recruiters! #halloween #recruitmentlondon #lifesciencerecruitment
-
-
A big thank you to Serena Vigano as she celebrates one year at Mantell Associates! Serena joined MA in October 2024, and has since become an integral part of our CDMO and Cell & Gene Therapy division. She has signed multiple clients, built a solid network across Europe and the US, and won company awards the past two quarters. Congratulations on your one year anniversary Serena - here's to the next! #workanniversary #recruitmentteam #recruitmentlondon
-
-
Lifecore Biomedical, an integrated CDMO, and PolyPeptide Group, a global peptide contract development and manufacturer, entered a collaboration agreement aimed at providing an integrated solution for peptide-based pharmaceutical customers in the U.S. Read more below: https://lnkd.in/ejBWeCtx #pharmanews #peptides #pharmamanufacturing